[1] Shen H, Kreisel D, Goldstein DR.Processes of sterile inflammation[J]. Journal of immunology, 2013, 191(6): 2857-2863. [2] Kalyanaraman B.Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms[J]. Redox biology, 2013, 1(1): 244-257. [3] Kusch A, Hoff U, Bubalo G, et al.Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury[J]. Acta Physiol, 2013, 208(1): 25-40. [4] Wang Y, He J, Pei X, et al.Systematic review and meta-analysis of mesenchymal stem/stromal cells therapy for impaired renal function in small animal models[J]. Nephrology, 2013, 18(3): 201-208. [5] Pae M, Wu D.Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications[J]. Food & Function, 2013, 4(9): 1287-1303. [6] Camfield DA, Stough C, Farrimond J, et al.Acute effects of tea constituents L-theanine, caffeine, and epigallocatechin gallate on cognitive function and mood: a systematic review and meta-analysis[J]. Nutr Rev, 2014, 72(8): 507-522. [7] Lv J, Feng M, Zhang L, et al.Protective effect of epigallocatechin gallate, a major constituent of green tea, against renalischemia-reperfusion injury in rats[J]. Int Urol Nephrol, 2015, 47(8): 1429-1435. [8] Legeay S, Rodier M, Fillon L, et al.Epigallocatechin gallate: a review of its beneficial properties to prevent metabolic syndrome[J]. Nutrients, 2015, 7(7): 5443-5468. [9] Takizawa Y, Kitazato T, Kishimoto H, et al.Effects of antioxidants on drug absorption in in vivo intestinal ischemia/reperfusion[J]. Eur J Drug Metab Pharmacokinet, 2011, 35(3/4): 89-95. [10] Zhang F, Li N, Jiang L, et al.Neuroprotective Effects of (-)-epigallocatechin-3-gallate against focal cerebralischemia/reperfusion injury in rats through attenuation of inflammation[J]. Neurochem Res, 2015, 40(8): 1691-1698. [11] Lee SK, Kim JH, Kim JS, et al.Polyphenol (-)-epigallocatechin gallate-induced cardioprotection may attenuate ischemia-reperfusion injury through adenosine receptor activation: a preliminary study[J]. Korean J Anesthesiol, 2012, 63(4): 340-345. [12] Vaseva AV, Moll UM.The mitochondrial p53 pathway[J]. Biochim Biophys Acta, 2009, 1787(5): 414-420. [13] Miura T, Nishihara M, Miki T.Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in myocardial protection against ischemia/reperfusion injury[J]. J Pharmacol Sci, 2009, 109(2): 162-167. [14] Xia Y, He Z, Liu B, et al.Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the Wnt/β-catenin signaling pathway[J]. Mol Med Rep, 2015, 12(3): 4530-4537. [15] Szlachcic WJ, Switonski PM, Krzyzosiak WJ, et al.Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway[J]. Dis Model Mech, 2015, 8(9): 1047-1057. |